Profil
Gisela Mautner is currently a Member at The CEO Institute, Inc. and a Member at the Australia Institute of Co. Directors.
Former roles include Chief Executive Officer, MD & Director at Noxopharm Ltd. from 2022 to 2026, and Independent Non-Executive Director at Nyrada, Inc. from 2022 to 2025.
Education includes graduate studies at Harvard University, an MBA from Northwestern University, and a doctorate from Ludwig-Maximilians-Universität München.
Aktiva positioner av Gisela Mautner
| Företag | Position | Start |
|---|---|---|
Australia Institute of Co. Directors | Företagsledare/Principal | - |
The CEO Institute, Inc.
The CEO Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Offers executive consulting services | Företagsledare/Principal | - |
Tidigare kända positioner av Gisela Mautner
| Företag | Position | Slut |
|---|---|---|
| NOXOPHARM LIMITED | Verkställande Direktör | 2026-04-15 |
| NYRADA INC. | Direktör/Styrelseledamot | 2025-11-12 |
Gisela Mautners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The CEO Institute, Inc.
The CEO Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Offers executive consulting services | Commercial Services |
Australia Institute of Co. Directors | |
Noxopharm Ltd.
Noxopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Nyrada, Inc.
Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs | Health Technology |
















